[Studies on a new aminoglycoside antibiotic, amikacin (BB-K8) in pediatrics (author's transl)].
D000293:Adolescent; D000613:Aminobutyrates / Q000031:analogs & derivatives / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D002648:Child; D002675:Child, Preschool; D003556:Cystitis / Q000188:drug therapy; D004341:Drug Evaluation; D004653:Empyema / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D007612:Kanamycin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D008199:Lymphadenitis / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D011014:Pneumonia / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011704:Pyelonephritis / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013363:Submandibular Gland; D014069:Tonsillitis / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000613:Aminobutyrates; D007612:Kanamycin